The first veterinary blockchain aiming at health and longevity

What TAILS tokens?
Leave your email and we’ll notify you about the news of the project or next investment round.

This project is about:

What is HealthyTail?

HealthyTail is a project devoted to health and longevity of cats and dogs - most popular domesticated pets. By using next-generation sequencing technology and by processing a very large amount of genomic data it is possible to identify disease-specific genomic variation patterns and provide a personalized treatment and recommendations for a pet.

Stage 1

Data platform & Diagnostics
About Stage 1

Stage 2

Healthy kittens & puppies
About Stage 2

Stage 3

Longevity for kittens & puppies
About Stage 3


January 2018
first samples gathered
February 2018
samples sequenced
March 2018
data analysis complete, 10 genetic markers-candidates found
April 2018
blockchain data platform ready
May 2018
June 2018
blockchain distributed compute platform ready
July 2018
August 2018
proteins obtained for genetic based drugs
September 2018
database enlargement, 50 genetic markers-candidates found
October 2018
November 2018
December 2018
longevity genetic variations defined
January 2019
March 2019
March 2019
second drug designed, longevity experimental drug designed
September 2019
longevity for kittens & puppies
October 2019

Take care of the health of your animal before it gets ill

join us

The team

The team consists of the first in the world bioinformaticians, geneticists, biologists, pet owners, veterinarians and seasoned IT professionals. They have a proven track record for pet genetics and high-cited publications.

Vladimir Suvorov
Ideology. Big Data & Data Science
Worked for: EMC, Cavium.
13 years in IT. R&D Storage and
Compute Solutions expert.
Ideologist of EMC Bioinformatics solution
presented on BioIT World 2015.
Big Data expert, Data Science challenges winner.
US patents & scientific publications author. Supervisor of projects total cap $50m.
Entrepreneur, BOINC activist, investor in cryptocurrencies and stocks.
Expert in startup community.
Dr. Ilya Dukhovlinov
Pharma expert
PhD in Biology. 45 publications in international scientific journals.
Training and teaching in Europe and USA.
Experience of the management of R&D projects in biotechnologies more than 15 years.
A lot of inventions and more
than 40 patents registered.
Inventions were included in TOP 100
of inventions of Russia 2015.
Jose Grau
Head of HealthyTail Europe
Geneticist and bioinformatician in Genetics department at Museum für Naturkunde Berlin, Germany.
Worked for SMB Services in Molecular Biology GmBH.
PhD in Biology by Humboldt-Universität zu Berlin, Germany.
MSc in Zoology by Universidade de São Paulo, Brazil.
Expert in Next generation sequencing data analysis and genomics of non-model organisms.

Dr. Alex Komissarov
Chief project scientist
Worked for: Institute of Cytology, Russian Academy of Sciences, Theodorius Dobzhansky Center of Genomic Bioinformatics. PhD in biology.
Expert in genome repeats studies. Expert in NLP, ML and DeepLearning.
Co-author of “Annotated features of domestic pet – Felis petus genome” 2014. GigaScience 3(1), 13.
More than 20 high-cited publications about animal genomes and annotations.
Andrew Shevchenko
GWAS expert
Worked for: Laboratory of Molecular Virology, State Research Institute of Highly Pure Biochemicals, St.Petersburg, Russia The Biomedical Center, St.Petersburg, Russia.
Worked for Theodosius Dobzhansky Center since its' foundation in 2011.
Expert in GWAS (Genome-Wide Association Studies), virology, epidemiology, HIV.
Co-author of the GWATCH web platform (Genome-Wide Association Tracks Chromosome Highway).
Serge Kliver
Bioinformatician and partnership developer
Worked for: University of Nebraska, Ksivalue, Theodorius Dobzhansky Center of Genomic Bioinformatics, St.­Petersburg State University.
Genomic pipeline and sequencing
quality specialist.
Bioinformatics tools author.
Roman Pavlov
Hacker & Developer
Worked for: Cryptopay. Java & AWS guru.
Knows more than 10 programming languages. Software architect. System administrator & Security specialist. Crypto enthusiast.
Dr. Veronika Guseva
PhD in Veterinary Science. More than 7 years of hands-on practice in Veterinary clinics.
Animal heart diseases diagnostics specialist. Official veterinary of a horse racing club.
Developer of a technology “Plasmolifting-animal”.
Local veterinary community leader. Animal breeders & clubs advisor.
Alexey Alekseev
Financial & PM expert
15 years of leading experience, 7 years of project management experience.
Experience of management of teams up to 250 people and projects annual budget over $30m.
The managing director of the company entering in TOP-10 in finance sphere, the co-founder of startup in biotech R&D.
Experience in launching partner projects with IKEA, Sberbank, the Russian Railway, St.Petersburg Bank, Svyaznoy, VIM-Airlines, Rostelecom, and others.
Lada Murashova
Specialist in veterinary immunology and anaesthesiology with 8 years of experience.
Postgraduate student in cytology and histology in St.Petersburg State University.
Julia Dmitrieva
Communications & marketing
PhD in political science.
Expertise in international research cooperation management between leading universities worldwide and international educational consulting,
marketing analytics and public relations within university foreign affairs policy for St. Petersburg State University.
Worked for international outdoor company Red Fox (marketing and PR management).
Natalia Nifantova
Chief media officer
Science writer and editor.
Journalist in several popular science magazines.
The proud owner (and the best friend) of Manny the cat.
Making science and technology understandable since 2011.


Dr. Stephen J O’Brian
Scientific Advisor
World-known star US geneticist.
Chief of the Laboratory of Genomic Diversity at the National Cancer Institute (NCI), National Institutes of Health (NIH) from 1986 to 2011.
Founder of Genome10K project.
Dr. O’Brien is the author or co-author of over 800 scientific articles and the editor of fourteen volumes.
Dr. Brian Kennedy
Scientific advisor
Brian K. Kennedy, PhD (Massachusetts Institute of Technology), has an international reputation for his work in the basic biology of aging. He became the Buck Institute’s second CEO in July, 2010, coming from the University of Washington in Seattle where he served in the Department of Biochemistry. His current work involves nutrient signaling pathways linked to dietary restriction, particularly the TOR pathway. He also studies A-type nuclear lamins, which are targets for mutation in Hutchinson-Gilford progeria syndrome. Dr. Kennedy has served on the National Institutes of Health Cellular Mechanisms of Aging and Development study section since 2006, and on the grant review committee for American Federation for Aging Research Grants since 2006. He has published more than 60 manuscripts in prestigious journals including Cell, Nature, Science, and the Proceedings of the National Academy of Sciences. He has been an Associate Editor for the Journal of Gerontology since 2006, and also serves as a consultant for biotech and pharmaceutical companies.
Dr. Matt Kaeberlein

Ph.D.,  recognized globally for his research on the basic biology of aging. The premise of his research is that understanding the molecular mechanisms of aging will lead to interventions that slow the onset and progression of age-related chronic conditions, such as cancer, diabetes, kidney disease, heart disease, Alzheimer’s and others. The Kaeberlein Lab is located in the University of Washington Medical Center in Seattle. The lab has been in operation as part of the UW Pathology Department since March 1, 2006. Dr. Matt Kaeberlein is the primary investigator. Dr. Kaeberlein has been recognized with several awards, including a Breakthroughs in Gerontology Award from the Glenn Foundation, an Alzheimer’s Association Young Investigator Award, an Ellison Medical Foundation New Scholar in Aging Award, an Undergraduate Research Mentor of the Year Award, and a Murdock Trust Award. In 2011, he was named the Vincent Cristofalo Rising Star in Aging Research by the American Federation for Aging Research and appointed as a Fellow of the Gerontological Society of America, and in 2012 he joined the Board of Directors of the American Aging Association. Dr. Kaeberlein currently serves on the editorial boards for Science, Aging Cell, Cell Cycle, PloS One, Frontiers in Genetics of Aging, BMC Longevity and Healthspan, F1000 Research, Ageing Research Reviews, and BioEsssays. Dr. Kaeberlein is the Director of the Dog Aging Project, co-Director of the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging, the founding Director of the Healthy Aging and Longevity Research Institute, and the current President of the American Aging Association.
Dr. Urs Giger
Charlotte Newton Sheppard Chair of Medicine , University of Pennsylvania Director, Josephine Deubler Genetic Disease Testing Laboratory, University of Pennsylvania, Department of Clinical Studies, Philadelphia School of Veterinary Medicine, University of Pennsylvania Head of Clinical Program in Medical Genetics and Pediatrics, Department of Clinical Studies, Philadelphia School of Veterinary Medicine, University of Pennsylvania Director of Metabolic Genetics Screening Laboratory , Department of Clinical Studies, Philadelphia School of Veterinary Medicine, University of Pennsylvania 1988-present Secondary Appointment as (Assistant/Associate/Full) Professor of Medicine, Department of Clinical Studies, Philadelphia School of Veterinary Medicine, University of Pennsylvania FVH Spezialtierarzt für Kleintiere, Switzerland
Dr. Martin Meixner
Scientific Advisor
Expert in sequencing and processing genetic data
Entrepreneur in genetics, diagnostics and drug design
Hamid Djam
CTO Analytics
CTO of Analytics for EMC’s Emerging Technology Division. He joined EMC in 2010 as one of the founding members of the Big Data Solutions Engineering and Product Management team where he successfully set directions for Analytics product and solutions roadmap, brought in 3rd party partners and integrators such as Attunity and was instrumental in integrating Attunity as the Greenplum CDC engine. He assisted in the development of Brazil Big Data R&D center, and led global partner training and sales enablement efforts. Hamid also won the annual EMC innovation award for multi-tenant Hadoop implementations and registered a patent for Genomic Data Store on Hadoop in 2013. Most recently Hamid led the Big Data solutions development for VCE/Global Solutions Engineering organization, developing proven solutions, reference architecture and best practices.

Elena Golubkova
Scientific Advisor
PhD in biology, associate professor of genetics and biotechnology in St. Petersburg State University.
Expert in animal genetics and molecular genetics. Fields of scientific interests: nuclear export of RNA, spermatogenesis.
Author of more than 20 publications in international science journals.
Dr. Guillaume Filion

2007: PhD in Molecular Biology in the laboratory of Pierre-Antoine Defossez. Curie Institute Paris (France).
2008-2011: Postdoctoral research associate in the laboratory of Bas van Steensel. The Netherlands Cancer Institute, Amsterdam.
2012: Group Leader at the Center for Genomic Regulation (CRG) Barcelona, Spain.
   2012 RISE1 member of the EpiGeneSys network.
   EDITORIAL EXPERIENCE PLOS Computational Biology PLOS Genetics
2015: Zerone
2014: Seeq
2014: Starcode

Our partners

Business model

TAILS project brings in a unique opportunity to invest in longevity for everyone and your pet. Each stage of the project has added value, potential patents for the new drug design, and potential new our drugs based on plasmid for pet or human.

Our financial model expects the following revenue and costs:


48% Data
15% Drug Design & registration
7% Reagents & materials
7% Taxes
7% Logistics, Assets, IT
7% Personell
4% Accountant + Lawyer
3% Marketing
2% Patents registration

Earnings after 3 years

48% Diagnostics, mating, certification
35% Drugs
6% Patents
6% Data
5% Healthy animals
In 2 years the project will be economically efficient.

Earnings in 5 years

In 5 years the data and drugs will become the main driver of the economy - we will see that competitors, especially big pharma will be interested in the data network and will pay a lot for data to compete with HealthyTail - as we would like to benefit the community the target is not to own the market rather the goal is to build a new pet data economy.

52% Data
26% Drugs
9% Patents
9% Diagnostics, mating, certification
4% Healthy animals
Learn how can you earn money and make pets healthier
Download White paper


78%of TAILS - ICO,long-term funding reserves,community growth *
10%of TAILS - Founders (with vesting)
10%of TAILS - Advisors (with vesting)
2%of TAILS - forecast
*proportions will be determined before ICO
About TAILS tokens
Old Cat

A portrait of
a long-lived cat

The average life expectancy of a domestic cat is 14 years. But like among humans among cats there are amazing long-livers. The oldest cat in the world, named Cream Puff, whose age was officially recorded by the Guinness Book of Records lived for 38 years.
Little Cat

Cats in the

We could revolutionary improve our pets’ health through genetic researches. But firstly we should join the efforts of scientists and pet owners by information technologies.
Two cats

Cats in the
blockchain, part 2

Previously we found out that creating a sufficient database to search for genetic markers of diseases in cats and dogs is a difficult matter. It requires joint efforts of scientists, owners, breeders, veterinarians.
Little Cat

Cats in the

We could revolutionary improve our pets’ health through genetic researches. But firstly we should join the efforts of scientists and pet owners by information technologies.

Our contacts

Feel free to write us. We are always in touch with the community

+79214038423 - Vladimir Suvorov

Submit for Research